Since the heart has no capacity to synthesize carnitine, the homeostasis of the blood carnitine pool is crucial for the heart
Comparison: Injectable vs
One example is retatrutide, a triple agonist targeting GLP-1, GIP, and glucagon receptors, which demonstrated statistically significant weight loss (22.8-24.2%) and metabolic improvements in systolic and diastolic blood pressure and levels of glycated hemoglobin, fasting glucose, insulin, and lipids in a 48-week phase 2 trial, highlighting its potential for future obesity management
JACC Basic Transl Sci 2:297310 Savarese G, Lund LH (2017) Global public health burden of heart failure
In addition, research has shown that semaglutide also can help prevent heart attacks and strokes
GLP-1 side effects are no exception to this rule